VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
+5.66%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$80.1B
AUM Growth
+$9.71B
(+14%)
Cap. Flow
+$5.09B
Cap. Flow
% of AUM
6.36%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
1,430
New
62
Increased
858
Reduced
440
Closed
53
Top Buys
| 1 |
Lam Research
LRCX
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$552M |
| 3 |
ASML
ASML
|
+$336M |
| 4 |
Qualcomm
QCOM
|
+$290M |
| 5 |
NXP Semiconductors
NXPI
|
+$289M |
Top Sells
| 1 |
Kinross Gold
KGC
|
+$530M |
| 2 |
C.H. Robinson
CHRW
|
+$279M |
| 3 |
Philip Morris
PM
|
+$276M |
| 4 |
Tyler Technologies
TYL
|
+$265M |
| 5 |
RTX Corp
RTX
|
+$261M |
Sector Composition
| 1 | Technology | 40.72% |
| 2 | Materials | 26.94% |
| 3 | Healthcare | 7.04% |
| 4 | Industrials | 6.47% |
| 5 | Financials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
451
Chimera Investment
CIM
$1.18B
| $9.88M | 0.01% |
645,480
-39,093
| -6% | -$598K |
|
452
PACCAR
PCAR
$51.2B
| $9.81M | 0.01% |
94,494
+9,370
| +11% | +$973K |
|
|
EU
453
enCore Energy
EU
$430M
| $9.76M | 0.01% |
2,434,342
+1,148,056
| +89% | +$4.6M |
|
454
Neurocrine Biosciences
NBIX
$14.3B
| $9.62M | 0.01% |
83,582
-12,637
| -13% | -$1.45M |
|
455
Charles River Laboratories
CRL
$7.75B
| $9.57M | 0.01% |
51,273
-6,633
| -11% | -$1.24M |
|
456
Energy Select Sector SPDR Fund
XLE
$26.6B
| $9.55M | 0.01% |
106,363
-211
| -0.2% | -$18.9K |
|
457
Exact Sciences
EXAS
$10.5B
| $9.55M | 0.01% |
135,865
-17,484
| -11% | -$1.23M |
|
|
TWO
458
Two Harbors Investment
TWO
$1.07B
| $9.54M | 0.01% |
743,144
-114,102
| -13% | -$1.47M |
|
|
RC
459
Ready Capital
RC
$708M
| $9.51M | 0.01% |
1,366,040
+23,970
| +2% | +$167K |
|
460
Bank of New York Mellon
BK
$73.9B
| $9.49M | 0.01% |
124,258
-19,639
| -14% | -$1.5M |
|
461
Edison International
EIX
$21.1B
| $9.44M | 0.01% |
109,716
-24,294
| -18% | -$2.09M |
|
462
LPL Financial
LPLA
$27.2B
| $9.39M | 0.01% |
36,380
+13,814
| +61% | +$3.56M |
|
463
Toll Brothers
TOL
$14B
| $9.34M | 0.01% |
63,589
+18,169
| +40% | +$2.67M |
|
464
ResMed
RMD
$40.9B
| $9.34M | 0.01% |
39,334
+1,121
| +3% | +$266K |
|
465
Donaldson
DCI
$9.35B
| $9.33M | 0.01% |
126,211
+23,927
| +23% | +$1.77M |
|
466
Infosys
INFY
$70.5B
| $9.29M | 0.01% |
418,301
-49,070
| -10% | -$1.09M |
|
|
MFA
467
MFA Financial
MFA
$1.05B
| $9.26M | 0.01% |
764,393
-58,303
| -7% | -$707K |
|
468
BioMarin Pharmaceuticals
BMRN
$10.7B
| $9.25M | 0.01% |
132,132
-1,390
| -1% | -$97.3K |
|
469
Veralto
VLTO
$26.1B
| $9.2M | 0.01% |
82,906
+951
| +1% | +$105K |
|
470
Quanta Services
PWR
$55.6B
| $9.18M | 0.01% |
29,948
+29,611
| +8,787% | +$9.08M |
|
471
Gentex
GNTX
$6.19B
| $9.14M | 0.01% |
309,668
+132,322
| +75% | +$3.91M |
|
472
Insmed
INSM
$31.1B
| $9.14M | 0.01% |
+127,024
| New | +$9.14M |
|
|
DX
473
Dynex Capital
DX
$1.68B
| $9.13M | 0.01% |
724,876
+5,725
| +0.8% | +$72.1K |
|
474
Alexandria Real Estate Equities
ARE
$14.3B
| $9.08M | 0.01% |
75,737
+9,400
| +14% | +$1.13M |
|
475
Mondelez International
MDLZ
$81B
| $9.05M | 0.01% |
128,242
-65
| -0.1% | -$4.59K |
|